Stock Updates

Celgene Corporation (NASDAQ: CELG) – Is this large market cap stock undervalued?

Celgene Corporation (NASDAQ: CELG), is firmly in the large market cap category with market cap of 77559.48. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for Celgene Corporation is 100.29 (with a change from open of 0.75%), this in conjunction with a target price of 137.35. Volume today has so far reached 1770272, with an average volume of about 3989.89. The GAP for this stock, is -0.55%.

The P/E ratio is 42.02, bringing the forward P/E to a value of 14.32. The current EPS for Celgene Corporation, is 2.38, with a EPS growth for this year coming to a value of -18.80%. Performance has been interesting with performance year to date coming to -16.42%.

Looking further into the growth statistics for Celgene Corporation, EPS is looking like it will grow 22.47% in the next year. Looking even further it is projected to be 21.87%. Quarter over quarter is 72.90% for EPS growth and for sales growth quarter over quarter it is 20.90%. Looking at past EPS growth statistics we see that for the past five years it has been 15.70%. Sales growth for the past five years has in fact been 20.60%.

Looking at the ownership, we see that the insider ownership is at 0.20% and institutional ownership is 79.30%. Shares outstanding is 774.82, while shares float is at a value of 773.05. Float short for Celgene Corporation is 0.90% and the short ratio is 1.74.

In terms of debt, long term debt/equity is 2.58, while the total debt/equity comes to 0. The ability to meet these debts, means that the current ratio is 4.6, and the quick ratio is 4.4. The most recent gross margin is 95.70% and their operating margin is 27.10%. The profit margin is 18.90%.

Celgene Corporation has seen returns on assets of 7.20%, and on investment, 8.90%. Return on equity is 35.10%. Price/Earnings to growth ratio is 1.92. Price/Sales ratio is at a value of 7.63, with Price/book ratio coming to 14 and Price/cash is 12.11, and finally Price/Free cash Flow is 26.21.

The simple moving averages are -7.61% and -4.56% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -21.88% and the 52 week low is 7.78%.

Celgene Corporation has a dividend yield of *TBA, with a current price of 100.29. The ability to pay this means the payout ratio is 0.00%. This is in an industry, Biotechnology, with equally high dividends from other companies in this sector, which it is Healthcare. Celgene Corporation is based in USA.

Performance in the Biotechnology industry means that Celgene Corporation has seen performance for the past week of -4.93%, with performance for the month coming to -4.24%. Looking at the data for the quarter it is at a value of -1.30%, and for the half year the performance is -12.02%. Volatility for this week is 1.89% and for the month this is 1.98%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment